Linked Life Data

16001110

Source:http://linkedlifedata.com/resource/pubmed/id/16001110

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-10-19
pubmed:abstractText
Atypical antipsychotic drug (APD)-induced weight gain causes non-compliance, increasing the risk of relapse and medical complications.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0033-3158
pubmed:author
pubmed:issnType
Print
pubmed:volume
182
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
220-31
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats.
pubmed:affiliation
Schizophrenia and Bipolar Disorders-In vivo Biology, Psychiatry CEDD, GlaxoSmithKline PLC, Harlow, Essex, CM19 5AW, UK. mikhail.m.kalinichev@gsk.com
pubmed:publicationType
Journal Article, Comparative Study